| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| CCKBR |
cholecystokinin B receptor |
11p15.4 |
1(1/0/0)
|
IDA[10913157]
|
| CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
1(0/1/0)
|
TAS[2739737]
|
| IL6 |
interleukin 6 |
7p21-p15 |
1(0/1/0)
|
IDA[2261637]; IMP[18719127]
|
| GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
3p21.31 |
1(0/1/0)
|
IEA
|
| EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
IDA[7736574]
|
| CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
IMP[16280133]
|
| ADM |
adrenomedullin |
11p15.4 |
1(1/0/0)
|
IEA
|
| ADCYAP1 |
adenylate cyclase activating polypeptide 1 (pituitary) |
18p11 |
3(1/2/0)
|
IEA
|
| FGFR2 |
fibroblast growth factor receptor 2 |
10q25.3-q26 |
2(1/1/0)
|
IDA[8663044]; IGI[8663044]; IMP[15629145]
|
| DLG1 |
discs, large homolog 1 (Drosophila) |
3q29 |
2(1/1/0)
|
IEA
|
| POU3F2 |
POU class 3 homeobox 2 |
6q16.2 |
1(1/0/0)
|
IDA[15024079]
|
| CTSH |
cathepsin H |
15q25.1 |
1(0/0/1)
|
ISS
|
| IFNG |
interferon, gamma |
12q14 |
2(2/0/0)
|
ISS
|
| NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
15q24-q25 |
2(2/0/0)
|
IDA[23027130]
|
| S100B |
S100 calcium binding protein B |
21q22.3 |
2(1/1/0)
|
IEA
|
| PTGFR |
prostaglandin F receptor (FP) |
1p31.1 |
1(1/0/0)
|
IMP[18508192]
|
| CDK13 |
cyclin-dependent kinase 13 |
7p14.1 |
1(1/0/0)
|
TAS[1731328]
|
| IGF1 |
insulin-like growth factor 1 (somatomedin C) |
12q23.2 |
1(1/0/0)
|
IDA[12746903]
|
| SIRT1 |
sirtuin 1 |
10q21 |
1(0/1/0)
|
IMP[21807113]
|
| NAMPT |
nicotinamide phosphoribosyltransferase |
7q22.3 |
1(1/0/0)
|
TAS[8289818]
|
| HOXA3 |
homeobox A3 |
7p15.2 |
1(1/0/0)
|
IEA
|
| ADRA2A |
adrenoceptor alpha 2A |
10q25.2 |
1(0/1/0)
|
TAS[10896916]
|
| CCK |
cholecystokinin |
3p22.1 |
2(0/1/1)
|
IEA
|
| EGR4 |
early growth response 4 |
2p13 |
1(0/1/0)
|
TAS[1658795]
|
| TSHR |
thyroid stimulating hormone receptor |
14q24-q31 |
1(1/0/0)
|
TAS[7920658]
|
| PRKCZ |
protein kinase C, zeta |
1p36.33-p36.2 |
1(1/0/0)
|
IEA
|
| ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
15q25.1 |
1(0/1/0)
|
IEA
|
| MAB21L1 |
mab-21-like 1 (C. elegans) |
13q13.3 |
1(0/1/0)
|
IEA
|
| TIPIN |
TIMELESS interacting protein |
15q22.31 |
2(0/2/0)
|
IMP[17102137]
|
| NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
9q22.1 |
3(1/1/1)
|
ISS
|
| CDC25B |
cell division cycle 25B |
20p13 |
1(0/1/0)
|
TAS[8276402]
|
| GDNF |
glial cell derived neurotrophic factor |
5p13.1-p12 |
1(1/0/0)
|
IDA[22897442]
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
5q11.2-q13 |
3(2/1/0)
|
TAS[1330092]
|
| CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
20p13 |
2(0/2/0)
|
IDA[20625391]
|
| DRD3 |
dopamine receptor D3 |
3q13.3 |
19(4/15/0)
|
IEA
|
| CRH |
corticotropin releasing hormone |
8q13 |
2(1/1/0)
|
IEA
|
| ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
IMP[8617750]
|
| ALOX12 |
arachidonate 12-lipoxygenase |
17p13.1 |
2(1/1/0)
|
IMP[15010818]; ISS
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
IEA
|
| VIP |
vasoactive intestinal peptide |
6q24-q27 |
1(1/0/0)
|
TAS[8389448]
|
| TFAP2B |
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
6p12 |
1(0/1/0)
|
IDA[17525748]
|
| HES1 |
hes family bHLH transcription factor 1 |
3q28-q29 |
1(0/1/0)
|
ISS
|
| PPARD |
peroxisome proliferator-activated receptor delta |
6p21.2 |
1(1/0/0)
|
IEA
|
| INS |
insulin |
11p15.5 |
1(0/1/0)
|
IDA[17925406]
|
Basic Info
